Anzeige
Meldung des Tages: Warum Kupfer und Silber aus Nevada plötzlich wieder im Fokus stehen könnten

PulteGroup Aktie News

Aktie
WKN:  854435 ISIN:  US7458671010 US-Symbol:  PHM Branche:  Gebrauchsgüter Land:  USA
123,27 $
+0,00 $
0,00%
103,05 € 01:00:00 Uhr
Depot/Watchlist
Marktkapitalisierung *
20,77 Mrd. €
Streubesitz
3,15%
KGV
7,28
Dividende
0,92 $
Dividendenrendite
0,79%
neu: Nachhaltigkeits-Score
24 %
Index-Zuordnung
S&P 500
Weiter aufwärts? Long handeln - Jetzt mit Hebel 8,77: MM8D6B
Werbung

PulteGroup News

18.12.25 - Businesswire
Del Webb Explore Breaks Ground on Model Homes at North River Ranch
PulteGroup’s Del Webb Explore brand is excited to announce that construction is officially underway on model homes at Del Webb Explore North River Ranch, marking a major ...
10.12.25 - Businesswire
Del Webb Announces Grand Opening of The Lake House, Amenity Center at Kensington Ridge
Del Webb, the nation’s leading builder of active adult communities for those 55 and older, is proud to announce the grand opening of the highly anticipated clubhouse and amenity ...
04.12.25 - Businesswire
PulteGroup Reveals Home Design Trends for 2026
Design trends are lasting longer. What's popular today remains relevant tomorrow, and that endurance reflects something bigger. Homebuyers are stepping away from constant ...
04.12.25 - Businesswire
PulteGroup’s Fourth Quarter 2025 Earnings Release and Webcast Conference Call Scheduled for January 29, 2026
PulteGroup, Inc. (NYSE: PHM) today announced that it will release its fourth quarter 2025 financial results before the market opens on Thursday, January 29, 2026. The Company will ...
01.12.25 - Businesswire
PulteGroup to Attend the 2025 Goldman Sachs Industrials and Materials Conference
In conjunction with its upcoming attendance at the 2025 Goldman Sachs Industrials on Thursday December 4, 2025, PulteGroup, Inc. (NYSE: PHM) has posted a new investor ...
19.11.25 - Businesswire
PulteGroup Increases Quarterly Cash Dividend by 18% to $0.26 Per Share
PulteGroup, Inc. (NYSE: PHM) announced today that its Board of Directors has voted to increase the Company’s quarterly dividend by 18% to $0.26 per common share. The increase ...
17.11.25 - Businesswire
PulteGroup Initiates Strategic Expansion into Cincinnati Market
Building on its longstanding success in the cities of Cleveland and Columbus, PulteGroup, Inc. (NYSE: PHM), the nation's third largest homebuilder, announces its plans to enter ...
13.11.25 - Businesswire
Del Webb Announces Grand Opening of New Greater Palm Springs Community, Desert Retreat
Del Webb, the nation’s leading builder of active-​adult communities for those 55 and older, today announced the grand opening of its newest community, Del Webb Desert Retreat. A ...
10.11.25 - Businesswire
PulteGroup Celebrates Veterans Day with More Than Words: Building Homes and Careers for Those Who Served
PulteGroup honors America’s wounded veterans and transitioning service members with action. The nation’s third-​largest homebuilder has delivered over 100 mortgage-​free homes ...
03.09.25 - PR Newswire
NYSE Content Advisory: Pre-Market Update + Alphabet shares pop 7% to lift S&P 500
NYSE Content Advisory: Pre-​Market Update + Alphabet shares pop 7% to lift S&P 500 PR Newswire
03.09.25 - PR Newswire
NYSE Content Advisory: Pre-Market Update + Alphabet shares pop 7% to lift S&P 500
NYSE Content Advisory: Pre-​Market Update + Alphabet shares pop 7% to lift S&P 500 PR Newswire
09.06.25 - wallstreetONLINE Redaktion
Angebot hoch, Käufer streiken: Die USA stehen an der Schwelle zur Immobilienkrise
Hartnäckig ohe Hypothekenzinsen und wirtschaftliche Un­sicher­heit dämpfen in den USA die Kaufbereitschaft der Verbraucher. Die Aussichten für den Immobilienmarkt sind ...
03.06.25 - PR Newswire
PharmaMar präsentiert auf der ASCO dass Zepzelca® (lurbinectedin) in Kombination mit Atezolizumab (Tecentriq®) das Überleben als Erstlinien-Erhaltungstherapie bei kleinzelligem Lungenkrebs
PharmaMar präsentiert auf der ASCO dass Zepzelca® (lurbinectedin) in Kombination mit Atezolizumab (Tecentriq®) das Überleben als Erstlinien-​Erhaltungstherapie bei ...
03.06.25 - PR Newswire
PharmaMar presents at ASCO that the Zepzelca®(lurbinectedin) and atezolizumab (Tecentriq®) combination significantly improves survival as first-line maintenance therapy for extensive-stage small cell lung cancer
PharmaMar presents at ASCO that the Zepzelca®(lurbinectedin) and atezolizumab (Tecentriq®) combination significantly improves survival as first-​line maintenance therapy for ...

Newssuche

Videos

newspaper
27.01.26 +3,71%
Technical Trading: Pfund Short
GBP/USD Short Typ: Turbo Open End WKN: VH3A2E Hebel: 2 Laufzeit: OpenEnd Einstieg: Market ... Mehr »